Lifestyle Medicine and Chronic Pulmonary Disease

  • Glen B. Chun
  • Charles A. PowellEmail author


Lifestyle medicine plays an important role in the prevention and management of chronic pulmonary disease. Presently, medical treatment options available for chronic pulmonary diseases can improve respiratory symptoms and quality of life, but scientific evidence shows that attention to lifestyle medicine issues can further enhance the benefit of these therapies. This chapter will focus on four specific chronic pulmonary diseases: cystic fibrosis, chronic obstructive pulmonary disease, asthma, and interstitial lung disease. Relevant lifestyle interventions that can significantly improve quality of life in patients with these diseases are discussed.


Cystic fibrosis (CF) Chronic obstructive pulmonary disease (COPD) Asthma Interstitial lung disease (ILD) 



Activities of daily living


Bone mineral density


Body mass index


Cystic fibrosis


Coefficient of fat absorption


Cystic fibrosis transmembrane conductance regulator


Chronic obstructive pulmonary disease


Dietary approaches to stop hypertension


Distal intestinal obstruction syndrome


Desquamative interstitial pneumonia


End-expiratory lung volume


Exocrine pancreatic insufficiency


Expiratory reserve volume


Fecal pancreatic elastase-1


Forced expiratory volume at 1 s


Fat-free mass


Forced vital capacity




Interstitial lung disease




Idiopathic pulmonary fibrosis


Methylmalonic acid


N-acetyl cysteine


Non-rapid eye movement


Obstructive sleep apnea


Pancreatic enzyme replacement therapy


Pulmonary Langerhans’ cell histiocytosis


Polymorphonuclear leukocytes


Parenteral nutrition


Pack per day


Respiratory bronchiolitis-associated interstitial lung disease


Resting energy expenditure


Reactive oxygen species


Total sleep time


  1. 1.
    Cahill K, et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5:Cd009329.Google Scholar
  2. 2.
    O’sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373(9678):1891–904.CrossRefPubMedGoogle Scholar
  3. 3.
    Somaraju UR, Solis-Moya A. Pancreatic enzyme replacement therapy for people with cystic fibrosis. Cochrane Database Syst Rev. 2014;10:Cd008227.Google Scholar
  4. 4.
    Stallings VA, et al. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc. 2008;108(5):832–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Sinaasappel M, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros. 2002;1(2):51–75.CrossRefPubMedGoogle Scholar
  6. 6.
    Conway SP, Morton A, Wolfe S. Enteral tube feeding for cystic fibrosis. Cochrane Database Syst Rev, 2008;2:Cd001198.Google Scholar
  7. 7.
    Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 2011;4:55–73.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Bruno MJ, et al. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Am J Gastroenterol. 1995;90(9):1383–93.PubMedGoogle Scholar
  9. 9.
    Corey M, et al. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583–91.CrossRefPubMedGoogle Scholar
  10. 10.
    Donovan DS Jr., et al. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1892–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Ferguson JH, Chang AB. Vitamin D supplementation for cystic fibrosis. Cochrane Database Syst Rev. 2012;4:Cd007298.Google Scholar
  12. 12.
    Stalvey MS, Clines GA. Cystic fibrosis-related bone disease: insights into a growing problem. Curr Opin Endocrinol Diabetes Obes. 2013;20(6):547–52.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Tangpricha V, et al. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab. 2012;97(4):1082–93.CrossRefPubMedGoogle Scholar
  14. 14.
    Smyth AR, et al. European Cystic Fibrosis Society Standards of Care: best practice guidelines. J Cyst Fibros. 2014;13(Suppl 1): S23–42.CrossRefPubMedGoogle Scholar
  15. 15.
    Gaskin KJ. Nutritional care in children with cystic fibrosis: are our patients becoming better? Eur J Clin Nutr. 2013;67(5):558–64.CrossRefPubMedGoogle Scholar
  16. 16.
    Gueant JL, et al. Malabsorption of vitamin B12 in pancreatic insufficiency of the adult and of the child. Pancreas. 1990;5(5):559–67.CrossRefPubMedGoogle Scholar
  17. 17.
    Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149–60.CrossRefPubMedGoogle Scholar
  18. 18.
    Ciofu O, Lykkesfeldt J. Antioxidant supplementation for lung disease in cystic fibrosis. Cochrane Database Syst Rev. 2014;8:Cd007020.Google Scholar
  19. 19.
    Chinuck R, et al. Appetite stimulants for people with cystic fibrosis. Cochrane Database Syst Rev. 2014;7:Cd008190.Google Scholar
  20. 20.
    Eubanks V, et al. Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis. J Pediatr. 2002;140(4):439–44.CrossRefPubMedGoogle Scholar
  21. 21.
    Homnick DN, Marks JH, Rubin BK. The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis. J Aerosol Med. 2007;20(1):45–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Marchand V, et al. Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2000;31(3):264–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Schneiderman-Walker J, et al. A randomized controlled trial of a 3-year home exercise program in cystic fibrosis. J Pediatr. 2000;136(3):304–10.CrossRefPubMedGoogle Scholar
  24. 24.
    Fonseca Wald EL, et al. Dietary fibre and fatty acids in chronic obstructive pulmonary disease risk and progression: a systematic review. Respirology. 2014;19(2):176–84.CrossRefPubMedGoogle Scholar
  25. 25.
    Vestbo J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.CrossRefPubMedGoogle Scholar
  26. 26.
    Landbo C, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–61.CrossRefPubMedGoogle Scholar
  27. 27.
    Ora J, et al. Effect of obesity on respiratory mechanics during rest and exercise in COPD. J Appl Physiol (1985). 2011;111(1):10–9.CrossRefGoogle Scholar
  28. 28.
    Schols AM, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J. 2014;44(6):1504–20.CrossRefPubMedGoogle Scholar
  29. 29.
    O’Donnell DE, Ciavaglia CE, Neder JA. When obesity and chronic obstructive pulmonary disease collide. Physiological and clinical consequences. Ann Am Thorac Soc. 2014;11(4):635–44.CrossRefPubMedGoogle Scholar
  30. 30.
    Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1385–95.CrossRefPubMedGoogle Scholar
  31. 31.
    Schols AM. Nutrition as a metabolic modulator in COPD. Chest. 2013;144(4):1340–5.CrossRefPubMedGoogle Scholar
  32. 32.
    Ezzell L, Jensen GL. Malnutrition in chronic obstructive pulmonary disease. Am J Clin Nutr. 2000;72(6):1415–6.PubMedGoogle Scholar
  33. 33.
    Collins PF, Elia M, Stratton RJ. Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology. 2013;18(4):616–29.CrossRefPubMedGoogle Scholar
  34. 34.
    Britton JR, et al. Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med. 1995;151(5):1383–7.CrossRefPubMedGoogle Scholar
  35. 35.
    Chen R, et al. Association of dietary antioxidants and waist circumference with pulmonary function and airway obstruction. Am J Epidemiol. 2001;153(2):157–63.CrossRefPubMedGoogle Scholar
  36. 36.
    Chuwers P, et al. The protective effect of beta-carotene and retinol on ventilatory function in an asbestos-exposed cohort. Am J Respir Crit Care Med. 1997;155(3):1066–71.CrossRefPubMedGoogle Scholar
  37. 37.
    Ford ES, et al. Associations between antioxidants and all-cause mortality among US adults with obstructive lung function. Br J Nutr. 2014;112(10):1662–73.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Grievink L, et al. Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN study. Thorax. 1998;53(3):166–71.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Schunemann HJ, et al. Lung function in relation to intake of carotenoids and other antioxidant vitamins in a population-based study. Am J Epidemiol. 2002;155(5):463–71.CrossRefPubMedGoogle Scholar
  40. 40.
    Kan H, et al. Dietary fiber, lung function, and chronic obstructive pulmonary disease in the atherosclerosis risk in communities study. Am J Epidemiol. 2008;167(5):570–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Varraso R, Willett WC, Camargo CA Jr. Prospective study of dietary fiber and risk of chronic obstructive pulmonary disease among US women and men. Am J Epidemiol. 2010;171(7):776–84.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Zuo L, et al. Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments. Am J Physiol Lung Cell Mol Physiol. 2014;307(3):L205–18.CrossRefPubMedGoogle Scholar
  43. 43.
    Willemse BW, et al. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J. 2005;26(5):835–45.CrossRefPubMedGoogle Scholar
  44. 44.
    Simmons MS, et al. Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study. Eur Respir J. 2005;25(6):1011–7.CrossRefPubMedGoogle Scholar
  45. 45.
    Ind PW. COPD disease progression and airway inflammation: uncoupled by smoking cessation. Eur Respir J. 2005;26(5):764–6.CrossRefPubMedGoogle Scholar
  46. 46.
    Waschki B, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–42.CrossRefPubMedGoogle Scholar
  47. 47.
    Spruit MA, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–e64.CrossRefPubMedGoogle Scholar
  48. 48.
    Borges RC, Carvalho CR. Impact of resistance training in chronic obstructive pulmonary disease patients during periods of acute exacerbation. Arch Phys Med Rehabil. 2014;95(9):1638–45.CrossRefPubMedGoogle Scholar
  49. 49.
    O’Donnell DE, Gebke KB. Examining the role of activity, exercise, and pharmacology in mild COPD. Postgrad Med. 2014;126(5):135–45.CrossRefPubMedGoogle Scholar
  50. 50.
    Yohannes AM, Alexopoulos GS. Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes. Drugs Aging. 2014;31(7):483–92.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Blakemore A, et al. Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2014;9:501–12.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Maurer J, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43 s–56 s.Google Scholar
  53. 53.
    Whiteford HA, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–86.CrossRefPubMedGoogle Scholar
  54. 54.
    Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry. 2000;15(12):1090–6.CrossRefPubMedGoogle Scholar
  55. 55.
    Vincent EE, Singh SJ. Review article: addressing the sexual health of patients with COPD: the needs of the patient and implications for health care professionals. Chron Respir Dis. 2007;4(2):111–5.CrossRefPubMedGoogle Scholar
  56. 56.
    Fletcher EC, Martin RJ. Sexual dysfunction and erectile impotence in chronic obstructive pulmonary disease. Chest. 1982;81(4):413–21.CrossRefPubMedGoogle Scholar
  57. 57.
    Karadag F, et al. Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients. Respirology. 2007;12(2):248–53.CrossRefPubMedGoogle Scholar
  58. 58.
    Koseoglu N, et al. Erectile dysfunction prevalence and sexual function status in patients with chronic obstructive pulmonary disease. J Urol. 2005;174(1):249–52; discussion 252.CrossRefPubMedGoogle Scholar
  59. 59.
    Collins EG, et al. Sexual dysfunction in men with COPD: impact on quality of life and survival. Lung. 2012;190(5):545–56.CrossRefPubMedGoogle Scholar
  60. 60.
    Schonhofer B, et al. Sexuality in patients with noninvasive mechanical ventilation due to chronic respiratory failure. Am J Respir Crit Care Med. 2001;164(9):1612–7.CrossRefPubMedGoogle Scholar
  61. 61.
    Sanders MH, et al. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med. 2003;167(1):7–14.CrossRefPubMedGoogle Scholar
  62. 62.
    Tarrega J, et al. Predicting nocturnal hypoventilation in hypercapnic chronic obstructive pulmonary disease patients undergoing long-term oxygen therapy. Respiration. 2011;82(1):4–9.CrossRefPubMedGoogle Scholar
  63. 63.
    O’Donoghue FJ, et al. Sleep hypoventilation in hypercapnic chronic obstructive pulmonary disease: prevalence and associated factors. Eur Respir J. 2003;21(6):977–84.CrossRefPubMedGoogle Scholar
  64. 64.
    Holmedahl NH, et al. Sleep hypoventilation and daytime hypercapnia in stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:265–75.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Ma J, et al. DASH for asthma: a pilot study of the DASH diet in not-well-controlled adult asthma. Contemp Clin Trials. 2013;35(2):55–67.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Lv N, Xiao L, Ma J. Dietary pattern and asthma: a systematic review and meta-analysis. J Asthma Allergy. 2014;7:105–21.PubMedPubMedCentralGoogle Scholar
  67. 67.
    Masoli M, et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–78.CrossRefPubMedGoogle Scholar
  68. 68.
    Nurmatov U, Devereux G, Sheikh A. Nutrients and foods for the primary prevention of asthma and allergy: systematic review and meta-analysis. J Allergy Clin Immunol. 2011;127(3):724–33.e1–30.CrossRefPubMedGoogle Scholar
  69. 69.
    Lange NE, et al. Maternal dietary pattern during pregnancy is not associated with recurrent wheeze in children. J Allergy Clin Immunol. 2010;126(2):250–5, 255.e1–4.CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Martindale S, et al. Antioxidant intake in pregnancy in relation to wheeze and eczema in the first two years of life. Am J Respir Crit Care Med. 2005;171(2):121–8.CrossRefPubMedGoogle Scholar
  71. 71.
    Litonjua AA, et al. Maternal antioxidant intake in pregnancy and wheezing illnesses in children at 2 y of age. Am J Clin Nutr. 2006;84(4):903–11.PubMedPubMedCentralGoogle Scholar
  72. 72.
    Devereux G, et al. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am J Respir Crit Care Med. 2006;174(5):499–507.CrossRefPubMedGoogle Scholar
  73. 73.
    Miyake Y, et al. Consumption of vegetables, fruit, and antioxidants during pregnancy and wheeze and eczema in infants. Allergy. 2010;65(6):758–65.CrossRefPubMedGoogle Scholar
  74. 74.
    Miyake Y, et al. Maternal fat consumption during pregnancy and risk of wheeze and eczema in Japanese infants aged 16–24 months: the Osaka Maternal and Child Health Study. Thorax. 2009;64(9):815–21.CrossRefPubMedGoogle Scholar
  75. 75.
    Camargo CA Jr, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr. 2007;85(3):788–95.PubMedPubMedCentralGoogle Scholar
  76. 76.
    Devereux G, et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr. 2007;85(3):853–9.PubMedGoogle Scholar
  77. 77.
    Nwaru BI, et al. An exploratory study of the associations between maternal iron status in pregnancy and childhood wheeze and atopy. Br J Nutr. 2014;112(12):2018–27.CrossRefPubMedGoogle Scholar
  78. 78.
    Moreno-Macias H, Romieu I. Effects of antioxidant supplements and nutrients on patients with asthma and allergies. J Allergy Clin Immunol. 2014;133(5):1237–44; quiz 1245.CrossRefPubMedGoogle Scholar
  79. 79.
    Bunyavanich S, et al. Peanut, milk, and wheat intake during pregnancy is associated with reduced allergy and asthma in children. J Allergy Clin Immunol. 2014;133(5):1373–82.CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Grande AJ, et al. Water-based exercise for adults with asthma. Cochrane Database Syst Rev. 2014;7:Cd010456.Google Scholar
  81. 81.
    Carson KV, et al. Physical training for asthma. Cochrane Database Syst Rev. 2013;9:Cd001116.Google Scholar
  82. 82.
    Avallone KM, McLeish AC. Asthma and aerobic exercise: a review of the empirical literature. J Asthma. 2013;50(2):109–16.CrossRefPubMedGoogle Scholar
  83. 83.
    Pacheco DR, et al. Exercise-related quality of life in subjects with asthma: a systematic review. J Asthma. 2012;49(5):487–95.CrossRefPubMedGoogle Scholar
  84. 84.
    Malkia E, Impivaara O. Intensity of physical activity and respiratory function in subjects with and without bronchial asthma. Scand J Med Sci Sports. 1998;8(1):27–32.CrossRefPubMedGoogle Scholar
  85. 85.
    Sideleva O, et al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med. 2012;186(7):598–605.CrossRefPubMedPubMedCentralGoogle Scholar
  86. 86.
    Lange P, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339(17):1194–200.CrossRefPubMedGoogle Scholar
  87. 87.
    Pietinalho A, Pelkonen A, Rytila P. Linkage between smoking and asthma. Allergy. 2009;64(12):1722–7.CrossRefPubMedGoogle Scholar
  88. 88.
    Gilliland FD, et al. Regular smoking and asthma incidence in adolescents. Am J Respir Crit Care Med. 2006;174(10):1094–100.CrossRefPubMedPubMedCentralGoogle Scholar
  89. 89.
    Baumgartner KB, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997;155(1):242–8.CrossRefPubMedGoogle Scholar
  90. 90.
    Ryu JH, et al. Smoking-related interstitial lung diseases: a concise review. Eur Respir J. 2001;17(1):122–32.CrossRefPubMedGoogle Scholar
  91. 91.
    Baumgartner KB, et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. Am J Epidemiol. 2000;152(4):307–15.CrossRefPubMedGoogle Scholar
  92. 92.
    Vassallo R. Diffuse lung diseases in cigarette smokers. Semin Respir Crit Care Med. 2012;33(5):533–42.CrossRefPubMedGoogle Scholar
  93. 93.
    Vassallo R, Ryu JH. Smoking-related interstitial lung diseases. Clin Chest Med. 2012;33(1):165–78.CrossRefPubMedGoogle Scholar
  94. 94.
    du Bois RM, et al. 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2014;43(5):1421–9.CrossRefPubMedGoogle Scholar
  95. 95.
    Vainshelboim B, et al. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis. Lung. 2015;193(3):345–54. doi:10.1007/s00408-015-9703-0. Epub 2015 March 3.Google Scholar
  96. 96.
    Dowman L, et al. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2014;10:Cd006322.Google Scholar
  97. 97.
    Holland AE, et al. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63(6):549–54.CrossRefPubMedGoogle Scholar
  98. 98.
    Nishiyama O, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13(3):394–9.CrossRefPubMedGoogle Scholar
  99. 99.
    Lancaster LH, et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest. 2009;136(3):772–8.CrossRefPubMedPubMedCentralGoogle Scholar
  100. 100.
    Perez-Padilla R, et al. Breathing during sleep in patients with interstitial lung disease. Am Rev Respir Dis. 1985;132(2):224–9.PubMedGoogle Scholar
  101. 101.
    Bye PT, et al. Studies of oxygenation during sleep in patients with interstitial lung disease. Am Rev Respir Dis. 1984;129(1):27–32.PubMedGoogle Scholar
  102. 102.
    Won CH, Kryger M. Sleep in patients with restrictive lung disease. Clin Chest Med. 2014;35(3):505–12.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Division of Pulmonary, Critical Care and Sleep MedicineIcahn School of Medicine at Mount SinaiNew YorkUSA
  2. 2.Division of Pulmonary, Critical Care and Sleep MedicineIcahn School of Medicine at Mount SinaiNew YorkUSA

Personalised recommendations